As of November 2024, Sangamo Therapeutics has a market cap of $160.77M. This makes Sangamo Therapeutics the world's 18630th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $151.90M | 58.61% |
2023 | $95.77M | -82.80% |
2022 | $556.87M | -58.13% |
2021 | $1.33B | -51.95% |
2020 | $2.77B | 86.50% |
2019 | $1.48B | -27.09% |
2018 | $2.04B | -30.00% |
2017 | $2.91B | 437.70% |
2016 | $540.91M | -66.59% |
2015 | $1.62B | -39.97% |
2014 | $2.70B | 9.50% |
2013 | $2.46B | 131.11% |
2012 | $1.07B | 111.62% |
2011 | $503.67M | -57.23% |
2010 | $1.18B | 12.16% |
2009 | $1.05B | 70.11% |
2008 | $617.17M | -73.27% |
2007 | $2.31B | 97.27% |
2006 | $1.17B | 63.77% |
2005 | $714.71M | -32.83% |
2004 | $1.06B | 9.69% |
2003 | $970.09M | 81.73% |
2002 | $533.81M | -67.77% |
2001 | $1.66B | -52.10% |
2000 | $3.46B | - |